| Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade J Hsu, JJ Hodgins, M Marathe, CJ Nicolai, MC Bourgeois-Daigneault, ... The Journal of clinical investigation 128 (10), 4654-4668, 2018 | 703 | 2018 |
| Recognition of tumors by the innate immune system and natural killer cells A Marcus, BG Gowen, TW Thompson, A Iannello, M Ardolino, W Deng, ... Advances in immunology 122, 91-128, 2014 | 455 | 2014 |
| Neutrophils suppress intraluminal NK cell–mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells A Spiegel, MW Brooks, S Houshyar, F Reinhardt, M Ardolino, E Fessler, ... Cancer discovery 6 (6), 630-649, 2016 | 435 | 2016 |
| p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells A Iannello, TW Thompson, M Ardolino, SW Lowe, DH Raulet Journal of Experimental Medicine 210 (10), 2057-2069, 2013 | 424 | 2013 |
| NK cell self tolerance, responsiveness and missing self recognition N Shifrin, DH Raulet, M Ardolino Seminars in immunology 26 (2), 138-144, 2014 | 250 | 2014 |
| Cytokine therapy reverses NK cell anergy in MHC-deficient tumors M Ardolino, CS Azimi, A Iannello, TN Trevino, L Horan, L Zhang, W Deng, ... The Journal of clinical investigation 124 (11), 4781-4794, 2014 | 204 | 2014 |
| Killers 2.0: NK cell therapies at the forefront of cancer control JJ Hodgins, ST Khan, MM Park, RC Auer, M Ardolino The Journal of clinical investigation 129 (9), 3499-3510, 2019 | 193 | 2019 |
| Flattening the COVID-19 curve with natural killer cell based immunotherapies M Market, L Angka, AB Martel, D Bastin, O Olanubi, G Tennakoon, ... Frontiers in Immunology 11, 1512, 2020 | 156 | 2020 |
| DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK–T cell interaction M Ardolino, A Zingoni, C Cerboni, F Cecere, A Soriani, ML Iannitto, ... Blood, The Journal of the American Society of Hematology 117 (18), 4778-4786, 2011 | 151 | 2011 |
| Immunosurveillance and immunotherapy of tumors by innate immune cells A Iannello, TW Thompson, M Ardolino, A Marcus, DH Raulet Current opinion in immunology 38, 52-58, 2016 | 121 | 2016 |
| Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov.(2016) 6: 630–49. doi: 10.1158 … A Spiegel, MW Brooks, S Houshyar, F Reinhardt, M Ardolino, E Fessler, ... DOI: https://doi. org/10.1158/2159-8290. CD-15-1157, 630-649, 0 | 94 | |
| Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells C Cerboni, M Ardolino, A Santoni, A Zingoni Blood, The Journal of the American Society of Hematology 113 (13), 2955-2964, 2009 | 80 | 2009 |
| NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses A Zingoni, M Ardolino, A Santoni, C Cerboni Frontiers in immunology 3, 408, 2013 | 70 | 2013 |
| Immunotherapy for sarcomas: new frontiers and unveiled opportunities HK Birdi, A Jirovec, S Cortés-Kaplan, J Werier, C Nessim, JS Diallo, ... Journal for immunotherapy of cancer 9 (2), 2021 | 60 | 2021 |
| When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer MS Hasim, M Marotel, JJ Hodgins, E Vulpis, OJ Makinson, S Asif, HY Shih, ... Science Advances 8 (15), eabj3286, 2022 | 51 | 2022 |
| A role for host activation-induced cytidine deaminase in innate immune defense against KSHV E Bekerman, D Jeon, M Ardolino, L Coscoy PLoS pathogens 9 (11), e1003748, 2013 | 51 | 2013 |
| Cytokine treatment in cancer immunotherapy M Ardolino, J Hsu, DH Raulet Oncotarget 6 (23), 19346, 2015 | 39 | 2015 |
| Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire S Sheppard, C Triulzi, M Ardolino, D Serna, L Zhang, DH Raulet, ... Blood, The Journal of the American Society of Hematology 121 (25), 5025-5033, 2013 | 39 | 2013 |
| Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver C Di Censo, M Marotel, I Mattiola, L Müller, G Scarno, G Pietropaolo, ... European journal of immunology 51 (11), 2568-2575, 2021 | 35 | 2021 |
| The two-faces of NK cells in oncolytic virotherapy M Marotel, MS Hasim, A Hagerman, M Ardolino Cytokine & Growth Factor Reviews 56, 59-68, 2020 | 28 | 2020 |
David H. RAULETDistinguished Professor of Molecular and Cell Biology, University of California, Berkeley在 berkeley.edu 的电子邮件经过验证
